Roger Adsett insider trades

Open-market stock purchases and sales by Roger Adsett, Chief Operating Officer at INSMED Inc, from SEC Form 4 filings since Oct 3, 2016.

Recent trades

DateStockTradeValue
Aug 10, 2026INSM INSMED IncBought (not open market)—
Aug 10, 2026INSM INSMED IncSold$32M
Aug 10, 2026INSM INSMED IncBought (not open market)—
Aug 10, 2026INSM INSMED IncBought (not open market)—
Jun 11, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Jun 11, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Jun 3, 2026INSM INSMED IncSold$242K
May 13, 2026INSM INSMED IncSold$678K
Apr 1, 2026INSM INSMED IncSold$1.1M
Apr 1, 2026INSM INSMED IncSold$3.1M
Apr 1, 2026INSM INSMED IncSold$10.3M
Apr 1, 2026INSM INSMED IncBought (not open market)—
Feb 3, 2026INSM INSMED IncSold$124K
Jan 29, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Jan 8, 2026INSM INSMED IncSold$359K
Jan 7, 2026INSM INSMED IncSold$140K
Jan 6, 2026INSM INSMED IncSold$248K
Jan 2, 2026INSM INSMED IncBought (not open market)—
Jan 2, 2026INSM INSMED IncBought (not open market)—

Companies traded

  • INSM INSMED Inc: 1 buy, 45 sales, last Aug 10, 2026
  • DFTX Definium Therapeutics, Inc: other filings, last Jun 11, 2026
  • LABP Landos Biopharma, Inc: other filings, last May 23, 2024

Get free alerts when Roger Adsett files a new trade →